Shi-wen X, Pennington D, Holmes A, Leask A, Bradham D, Beauchamp J R, Fonseca C, du Bois R M, Martin G R, Black C M, Abraham D J
Centre for Rheumatology, Royal Free and University College Medical School, University College London (Royal Free Campus), Rowland Hill Street, London, NW3 2PF, United Kingdom.
Exp Cell Res. 2000 Aug 25;259(1):213-24. doi: 10.1006/excr.2000.4972.
We have used representational difference analysis (RDA) to identify up-regulated genes in skin fibroblasts from fibrotic lesions obtained from patients with systemic sclerosis (scleroderma). RDA of cDNA libraries derived from fibroblasts from involved and uninvolved skin detected several differentially expressed genes. One such gene consistently up-regulated in scleroderma cells coded for human connective tissue growth factor (CTGF). Other studies described here show that the CTGF protein is readily detected in cultures of systemic sclerosis fibroblasts but was not detected in comparable normal cells. High levels of CTGF are also evident in biological fluids from patients with systemic sclerosis. TGFbeta stimulates CTGF production in both normal and systemic sclerosis fibroblasts with the latter found to be higher producers. Moreover, an analysis of constitutive and TGFbeta-induced CTGF gene activation showed altered and elevated transcriptional responses in systemic sclerosis cells compared with controls. CTGF stimulated a two- to threefold increase in proalpha1(I) collagen and fibronectin synthesis by both dermal and lung fibroblasts in culture and promoted significant matrix remodeling of fibroblast-populated three-dimensional collagen lattices. A direct relation between the overexpression of CTGF and elevated collagen synthesis was suggested by the observation that transfection of a CMV-CTGF cDNA construct and protein expression in fibroblasts increased the transcription of a Col 1alpha2 promoter-reporter construct to levels seen in systemic sclerosis fibroblasts. Using Col 1alpha2 promoter deletion constructs the CTGF responsive element was localized to the first 379 bp upstream of the transcriptional start site. These data indicate that there is an overexpression of CTGF in the systemic sclerosis cells, probably due to increased gene transcription, and suggest that the dysregulation of CTGF production is an important factor in fibroblast activation and the excessive deposition of collagen in systemic sclerosis.
我们利用代表性差异分析(RDA)来鉴定系统性硬化症(硬皮病)患者纤维化病变处皮肤成纤维细胞中上调的基因。对来自受累皮肤和未受累皮肤的成纤维细胞的cDNA文库进行RDA分析,检测到了几个差异表达基因。其中一个在硬皮病细胞中持续上调的基因编码人结缔组织生长因子(CTGF)。本文所述的其他研究表明,在系统性硬化症成纤维细胞培养物中很容易检测到CTGF蛋白,但在正常对照细胞中未检测到。系统性硬化症患者的生物体液中也明显存在高水平的CTGF。转化生长因子β(TGFβ)可刺激正常和系统性硬化症成纤维细胞产生CTGF,且发现后者产生量更高。此外,对组成型和TGFβ诱导的CTGF基因激活的分析表明,与对照相比,系统性硬化症细胞中的转录反应发生改变且增强。CTGF可使培养的真皮和肺成纤维细胞的原α1(I)型胶原蛋白和纤连蛋白合成增加两到三倍,并促进成纤维细胞填充的三维胶原晶格发生显著的基质重塑。观察到转染CMV-CTGF cDNA构建体并在成纤维细胞中表达蛋白可使Col 1α2启动子-报告基因构建体的转录增加至系统性硬化症成纤维细胞中的水平,这表明CTGF的过表达与胶原蛋白合成增加之间存在直接关系。利用Col 1α2启动子缺失构建体,将CTGF反应元件定位到转录起始位点上游的前379 bp处。这些数据表明,系统性硬化症细胞中存在CTGF过表达,可能是由于基因转录增加所致,并提示CTGF产生失调是系统性硬化症中纤维母细胞激活和胶原蛋白过度沉积的一个重要因素。